More China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A news
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class ASZSE: 000999

China Resources Sanjiu Medical & Pharmaceutical Q1 Net Profit Down 15.3% Y/Y

Apr 24, 2026 at 10:28 AM UTC · Issued by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A

China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999:

  • Q1 NET PROFIT DOWN 15.3% Y/Y

Earlier from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A

  • China Resources Sanjiu Medical & Pharmaceutical Co: 2025 revenue up 14.43%, net profit up 1.58%, with robust R&D and major acquisitionMar 21
  • China Resources Sanjiu Medical & Pharma's 2025 Net Profit Up 1.6% Y/YMar 20
  • China Resources Sanjiu Medical & Pharmaceutical Prelim 2025 Net Profit Up 1.6%Feb 6
  • China Resources Sanjiu Medical & Pharmaceutical Co: Revenue surged but profit declined as acquisition and investment costs rose sharplyOct 25, 2025
All China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A news releases↗